E-LIB Suche - Ergebnisse für: Dohner, H.

1

The German Network for Personalized Medicine to enhance pat..:

Illert, A. L. ; Stenzinger, A. ; Bitzer, M....
Nature Medicine. 29 (2023) 6 - p. 1298-1301 , 2023

Link: https://doi.org/10.1038/..

2

Randomized phase-III study of low-dose cytarabine and etopo..:

Schlenk, R. F. ; Weber, D. ; Krzykalla, J....
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

3

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome a..:

Kuendgen, A. ; Nomdedeu, M. ; Tuechler, H....
Leukemia Research. 128 (2023) - p. 107226 , 2023

Link: https://doi.org/10.1016/..

4

P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIA..:

Stegelmann, F. ; Jahn, E. ; Koschmieder, S....
HemaSphere. 6 (2022) - p. 945-946 , 2022

Link: https://doi.org/10.1097/..

5

P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-..:

Wei, A. H. ; Döhner, H. ; Sayar, H....
HemaSphere. 6 (2022) - p. 397-398 , 2022

Link: https://doi.org/10.1097/..

6

P470: NGS-BASED MINIMAL RESIDUAL DISEASE DETECTION IN PERIP..:

Thiede, C. ; Schuster, C. ; Krippendorf, C....
HemaSphere. 6 (2022) - p. 369-370 , 2022

Link: https://doi.org/10.1097/..

7

P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS..:

Schuh, A. ; de Botton, S. ; Recher, C....
HemaSphere. 6 (2022) - p. 455-456 , 2022

Link: https://doi.org/10.1097/..

8

P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NE..:

de Botton, S. ; Choe, S. ; Marchione, D....
HemaSphere. 6 (2022) - p. 330-331 , 2022

Link: https://doi.org/10.1097/..

9

P557: HEMATOLOGIC IMPROVEMENTS WITH IVOSIDENIB + AZACITIDIN..:

Dohner, H. ; Montesinos, P. ; Vives Polo, S....
HemaSphere. 6 (2022) - p. 456-457 , 2022

Link: https://doi.org/10.1097/..

10

P448: PROGNOSTIC IMPACT OF SOMATIC CEBPA BZIP DOMAIN MUTATI..:

Ruecker, F. G. ; Corbacioglu, A. ; Theis, F....
HemaSphere. 6 (2022) - p. 348-349 , 2022

Link: https://doi.org/10.1097/..

11

P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN ..:

Garcia-Manero, G. ; Bart, S. ; McCloskey, J. K....
HemaSphere. 6 (2022) - p. 663-664 , 2022

Link: https://doi.org/10.1097/..

12

Topic: AS02-Epidemiology:

Kuendgen, A. ; Nomdedeu, M. ; Tuechler, H....
Leukemia Research. 108 (2021) - p. 106680.16 , 2021

Link: https://doi.org/10.1016/..

13

GENETIC MARKERS AND OUTCOME WITH FRONT LINE OBINUTUZUMAB PL..:

Tausch, E ; Schneider, C ; Yosifov, D...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

14

Therapy-related myelodysplastic syndromes deserve specific ..:

Kuendgen, A. ; Nomdedeu, M. ; Tuechler, H....
Leukemia. 35 (2020) 3 - p. 835-849 , 2020

Link: https://doi.org/10.1038/..

15

Residual abdominal lymphadenopathy after intensive frontlin..:

Fürstenau, M. ; Bahlo, J. ; Fink, A. M....
Leukemia. 34 (2019) 3 - p. 924-928 , 2019

Link: https://doi.org/10.1038/..